Company
United StatesPublic company, NASDAQ: LINLinde Inc. (NASDAQ: LIN), Neosho, MO – FDA Inspections
Inspection records and compliance data for Linde Inc. in Neosho, Missouri. 2 FDA inspections on record, last inspected February 06, 2025. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc. based in Neosho, Missouri, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected December 17, 2013. Last inspected February 6, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 6, 2025 | Not classified | Foods & Cosmetics | 1261336 |
| December 17, 2013 | NAI | Human Drugs · Drug Quality Assurance | 860959 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
1944018
Address
1601 Industrial Dr, Neosho, Missouri 64850, United States
Country
United States
ID: 3eba0dcd-4a78-4a39-af02-96b264464c4c